Methods: Four cases of uncontrolled T1DM managed by MDIs (and not insulin pumps) and deemed to have plateaued in their management were selected to retrospectively review to identify potential advantages of SIP/CGM along with telemedicine as a method of care delivery. The gene discussed is INS; the disease is type 1 diabetes mellitus.